The recommended composition of quadrivalent influenza vaccine for Australia in 2022 introduces two new strains for the A (H3N2)-like and B Victoria lineage viruses when compared to the composition of the trivalent and quadrivalent vaccines for Australia in 2021.

In 2022 there will be Egg & Cell based Quadrivalent and Trivalent Influenza Vaccines available in Australia.

The Egg-based quadrivalent influenza vaccine components for the Australian 2022 influenza season will contain the following: 1

  • An A/Victoria/2570/2019 (H1N1)pdm09-like virus;
  • An A/Darwin/9/2021 (H3N2)-like virus;
  • A B/Austria/1359417/2021-like (B/Victoria lineage) virus
  • A B/Phuket/3073/2013-like (B/Yamagata lineage) virus

The Cell-based quadrivalent influenza vaccine components for the Australian 2022 influenza season will contain the following: 1

  • An A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • An A/Darwin/6/2021 (H3N2)-like virus;
  • A B/Austria/1359417/2021 (B/Victoria lineage) virus
  • A B/Phuket/3073/2013-like (B/Yamagata lineage) virus

The trivalent influenza vaccine components for the Australian 2022 influenza season will contain the following: 1

  • An A/Victoria/2570/2019 (H1N1)pdm09-like virus;
  • An A/Darwin/9/2021 (H3N2)-like virus;
  • A B/Austria/1359417/2021 (B/Victoria lineage) virus

Vaccination is your best defence as recommended by the World Health Organisation 2


1. Australian Government, Dept Health and Ageing, Therapeutic Goods Administration. AIVC recommendations for the composition of influenza vaccine for Australia in 2022. Found at: https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2022 (Accessed 13 Oct 2021).
2. World Health Organisation Influenza factsheet No. 211, April 2009. Accessed 9 October 2014.